KORU Medical Systems, Inc. recently filed a Form 4 with the Securities and Exchange Commission (SEC), indicating significant changes in the ownership of the company’s securities. Form 4 is required to be filed with the SEC whenever there are changes in the holdings of company insiders, such as directors, officers, or shareholders with more than 10% of the company’s stock. Investors and analysts often closely monitor these filings to gauge the confidence and sentiment of insiders within the company.
KORU Medical Systems, Inc. is a company that specializes in the design, manufacture, and marketing of innovative medical devices, particularly in the field of home infusion therapy. The company’s products are aimed at improving the quality of life for patients who require infusion therapy. For more information about KORU Medical Systems, Inc., you can visit their website here.
Form 4 filings provide valuable insights into the buying and selling activities of insiders within a company, which can be indicative of their confidence in the company’s future performance. Investors and analysts use this information to make informed decisions about their own investment strategies.
Read More:
KORU Medical Systems, Inc. Submits Form 4 Filing to SEC – Issuer Details Revealed
Leave a Reply